Artigos de revistas sobre o tema "Psychotropic drugs – adverse effects"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Psychotropic drugs – adverse effects".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Goff, Donald C. "Adverse Effects of Psychotropic Drugs". Journal of Clinical Psychopharmacology 14, n.º 1 (fevereiro de 1994): 83. http://dx.doi.org/10.1097/00004714-199402000-00017.
Texto completo da fonteBalis, George U. "Adverse Effects of Psychotropic Drugs". Journal of Nervous and Mental Disease 182, n.º 3 (março de 1994): 191–92. http://dx.doi.org/10.1097/00005053-199403000-00020.
Texto completo da fonteMARDER, STEPHEN R. "Adverse Effects of Psychotropic Drugs". American Journal of Psychiatry 152, n.º 1 (janeiro de 1995): 146—a—146. http://dx.doi.org/10.1176/ajp.152.1.146-a.
Texto completo da fonteKhalil, Rami Bou, e Sami Richa. "Thyroid Adverse Effects of Psychotropic Drugs". Clinical Neuropharmacology 34, n.º 6 (2011): 248–55. http://dx.doi.org/10.1097/wnf.0b013e31823429a7.
Texto completo da fonteGullickson, Terri, e Brigittine French. "Review of Adverse Effects of Psychotropic Drugs." Contemporary Psychology: A Journal of Reviews 40, n.º 1 (janeiro de 1995): 75. http://dx.doi.org/10.1037/003381.
Texto completo da fonteGupta, Ankit, e Rakesh K. Chadda. "Adverse psychiatric effects of non-psychotropic medications". BJPsych Advances 22, n.º 5 (setembro de 2016): 325–34. http://dx.doi.org/10.1192/apt.bp.115.015735.
Texto completo da fonteBhuvaneswar, Chaya G., Ross J. Baldessarini, Veronica L. Harsh e Jonathan E. Alpert. "Adverse Endocrine and Metabolic Effects of Psychotropic Drugs". CNS Drugs 23, n.º 12 (dezembro de 2009): 1003–21. http://dx.doi.org/10.2165/11530020-000000000-00000.
Texto completo da fonteVívian Ferreira da Costa, Ana, Larissa De Carvalho Bezerra e Juliane Dos Anjos de Paula. "Use of psychotropic drugs in the treatment of fibromyalgia: a systematic review". Journal of Human Growth and Development 31, n.º 2 (3 de agosto de 2021): 336–45. http://dx.doi.org/10.36311/jhgd.v31.12228.
Texto completo da fontePetukhova, A. A., A. A. Panov, Ya V. Malygin e M. A. Kazanfarova. "Side effects of psychotropic drugs on eye". Russian Journal of Clinical Ophthalmology 21, n.º 1 (2021): 29–33. http://dx.doi.org/10.32364/2311-7729-2021-21-1-29-33.
Texto completo da fonteG, Siddesha, Justina M. Steefan e A. Naveen. "Adverse Effects of Antipsychotic Drugs - A Review". International Journal of Research and Review 10, n.º 9 (15 de setembro de 2023): 153–56. http://dx.doi.org/10.52403/ijrr.20230916.
Texto completo da fonteSeifert, Randall D. "Therapeutic Drug Monitoring: Psychotropic Drugs". Journal of Pharmacy Practice 2, n.º 6 (dezembro de 1989): 403–15. http://dx.doi.org/10.1177/089719008900200609.
Texto completo da fonteElmaataoui, Z., H. Belhadga e H. Kisra. "The metabolic syndrom and the prescription of psychotropic drugs in children and adolescents: three clinical cases". European Psychiatry 66, S1 (março de 2023): S749. http://dx.doi.org/10.1192/j.eurpsy.2023.1577.
Texto completo da fonteGupta, Sumeet, Mukesh Kripalani, Udayan Khastgir e Joe Reilly. "Management of the renal adverse effects of lithium". Advances in Psychiatric Treatment 19, n.º 6 (novembro de 2013): 457–66. http://dx.doi.org/10.1192/apt.bp.112.010306.
Texto completo da fonteGoodlet, Kellie J., Monika T. Zmarlicka e Alyssa M. Peckham. "Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs". CNS Spectrums 24, n.º 03 (8 de outubro de 2018): 287–312. http://dx.doi.org/10.1017/s109285291800113x.
Texto completo da fonteROCK, NICHOLAS L. "Possible Adverse Effects of Buspirone When Used with Other Psychotropic Drugs". Journal of Clinical Psychopharmacology 10, n.º 5 (outubro de 1990): 380. http://dx.doi.org/10.1097/00004714-199010000-00028.
Texto completo da fonteAlderman, Christopher P., e Michael J. Ryan. "Consumer Requests for Information regarding Psychotropic Drugs: Experience from a National Medicines Phone-In". Annals of Pharmacotherapy 31, n.º 11 (novembro de 1997): 1301–5. http://dx.doi.org/10.1177/106002809703101104.
Texto completo da fonteMula, Marco. "Psychotropic Effects of Anticonvulsant Drugs in Patients with Epilepsy". Clinical Medicine Insights: Therapeutics 2 (janeiro de 2010): CMT.S3285. http://dx.doi.org/10.4137/cmt.s3285.
Texto completo da fonteSepúlveda-Lizcano, Lizeth, Vivian Vanessa Arenas-Villamizar, Enna Beatriz Jaimes-Duarte, Henry García-Pacheco, Carlos Silva Paredes, Valmore Bermúdez e Diego Rivera-Porras. "Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review". European Journal of Investigation in Health, Psychology and Education 13, n.º 8 (12 de agosto de 2023): 1505–20. http://dx.doi.org/10.3390/ejihpe13080110.
Texto completo da fonteBaldwin, David, e Andrew Mayers. "Sexual side-effects of antidepressant and antipsychotic drugs". Advances in Psychiatric Treatment 9, n.º 3 (maio de 2003): 202–10. http://dx.doi.org/10.1192/apt.9.3.202.
Texto completo da fonteBotero, Beatriz, Erick Frota Gomes Figueiredo, Jesus Eden Bezerra da Costa, Méllory Nétaly de Oliveira Magalhães, Pablo Henrique Freitas de Almeida, Salomão Rocha Martim e Ytalo Thiago Praciano da Silva. "Efficacy and risks of the use of psychotropics drugs in children and adolescents with depression disorders: a literature review". Research, Society and Development 11, n.º 14 (27 de outubro de 2022): e304111436284. http://dx.doi.org/10.33448/rsd-v11i14.36284.
Texto completo da fontePiedad, John, Hugh Rickards, Frank M. C. Besag e Andrea E. Cavanna. "Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy". CNS Drugs 26, n.º 4 (abril de 2012): 319–35. http://dx.doi.org/10.2165/11599780-000000000-00000.
Texto completo da fonteAktepe, Evrim. "Endocrine and Metabolic Adverse Effects of Psychotropic Drugs in Children and Adolescents". TAF Preventive Medicine Bulletin 10, n.º 6 (2011): 741. http://dx.doi.org/10.5455/pmb.20110815113354.
Texto completo da fonteKANEKO, Koichi. "6.Adverse Effects on Brain Function of Psychotropic Drugs, Corticosteroids and Interferon". Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 48, n.º 2 (2017): 84–90. http://dx.doi.org/10.3999/jscpt.48.84.
Texto completo da fonteBiering, Páll, e Ingibjörg Hjaltadóttir. "The prevalence of psychiatric diagnoses and psychotropic medication in icelandic nursing homes from 2003 to 2018". Læknablaðið 107, n.º 01 (4 de janeiro de 2021): 11–16. http://dx.doi.org/10.17992/lbl.2021.01.615.
Texto completo da fonteStimmel, Glen L., e Mary A. Gutierrez. "Sexual Dysfunction and Psychotropic Medications". CNS Spectrums 11, S9 (2006): 24–30. http://dx.doi.org/10.1017/s1092852900026730.
Texto completo da fonteFlorian, A., C. Florian, A. Ignat, C. Voinea, L. Popescu, G. Ganea, C. Gherghe e L. Mateescu. "QT Prolongation: Psychotropic medication versus illicit drugs". European Psychiatry 65, S1 (junho de 2022): S446. http://dx.doi.org/10.1192/j.eurpsy.2022.1133.
Texto completo da fonteGurung, Aruna, Jugalkishore B. Jaju, Ganesh R. Pawar, Shrikant C. Dharmadhikari e Rajvardhan R. Solunke. "Study of drug utilization pattern and adverse drug reactions of psychotropic drugs in psychiatric inpatient department of tertiary care hospital". International Journal of Basic & Clinical Pharmacology 7, n.º 2 (23 de janeiro de 2018): 259. http://dx.doi.org/10.18203/2319-2003.ijbcp20180095.
Texto completo da fonteBishara, Delia, Chris Kalafatis e David Taylor. "Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents". Therapeutic Advances in Psychopharmacology 10 (janeiro de 2020): 204512532093530. http://dx.doi.org/10.1177/2045125320935306.
Texto completo da fonteGustafsson, Maria, Per-Olof Sandman, Stig Karlsson, Yngve Gustafson e Hugo Lövheim. "Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings". International Psychogeriatrics 25, n.º 9 (20 de junho de 2013): 1415–23. http://dx.doi.org/10.1017/s1041610213000859.
Texto completo da fonteGupta, Sumeet, Udayan Khastgir, Ogba Onwuchekwa e Ioana Varvari. "Monitoring the Adverse Effects of Psychotropic drugs – Need for An Evidence-Based Approach". GLOBAL PSYCHIATRY ARCHIVES 5, n.º 1 (1 de maio de 2022): 51–63. http://dx.doi.org/10.52095/gpa.2022.4362.1034.
Texto completo da fonteBaumann, P. "The AMSP-project: Pharmacovigilance in psychiatry - Presentation, challenges and results". European Psychiatry 29, S3 (novembro de 2014): 663. http://dx.doi.org/10.1016/j.eurpsy.2014.09.050.
Texto completo da fonteEustace, Andrew, Elaine Murray e Kelley Daly. "341 The Prevalence and Factors Associated with Anti-psychotic Prescribing on Admission to a Dementia Specific Nursing Home". Age and Ageing 48, Supplement_3 (setembro de 2019): iii17—iii65. http://dx.doi.org/10.1093/ageing/afz103.223.
Texto completo da fonteVerdoux, H. "Safety of psychotropic medicines: contribution from observational evidence". Epidemiology and Psychiatric Sciences 27, n.º 6 (30 de maio de 2018): 531–36. http://dx.doi.org/10.1017/s2045796018000276.
Texto completo da fonteKumari, Rani, Rachna Gupta, Manjeet Singh Bhatia e Suresh Kumar Gupta. "Assessment of adverse drug reactions of psychopharmacological drugs in patients of psychiatric disorders". Journal of Pharmacovigilance and Drug Research 2, n.º 2 (1 de junho de 2021): 27–32. http://dx.doi.org/10.53411/jpadr.2021.2.2.6.
Texto completo da fonteFreitas, Eliane Da Silva, Joaquim Alves Diniz, Natália Rodrigues Alves, Pedro Ivo Palacio Leite, Modesto Leite Rolim Neto e Poliana Moreira Medeiros de Carvalho. "Benzodiazepines use in elderly patients attended at a Public Pharmacy in Pernambuco Brazil". Amadeus International Multidisciplinary Journal 4, n.º 7 (27 de outubro de 2019): 203–16. http://dx.doi.org/10.14295/aimj.v4i7.91.
Texto completo da fonteFerreira, A. R., S. Martins, C. Dias, M. R. Simões e L. Fernandes. "Psychotropic Use in Elderly with Cognitive Impairment Living in Nursing Homes". European Psychiatry 41, S1 (abril de 2017): S174. http://dx.doi.org/10.1016/j.eurpsy.2017.01.2069.
Texto completo da fonteBingefors, Kerstin, Dag Isacson, Lars Von Knorring, Björn Smedby, Lisa Ekselius e Lawrence L. Kupper. "Antidepressant-treated Patients in Ambulatory Care". British Journal of Psychiatry 168, n.º 3 (março de 1996): 292–98. http://dx.doi.org/10.1192/bjp.168.3.292.
Texto completo da fonteBlom, Johanna, Elena Barisone, Marina Bertolotti, Daniela Caprino, Monica Cellini, Carlo Clerici, Chiara Colliva et al. "The Use of Psychotropic Medication in Pediatric Oncology for Acute Psychological and Psychiatric Problems: Balancing Risks and Benefits". Children 9, n.º 12 (30 de novembro de 2022): 1878. http://dx.doi.org/10.3390/children9121878.
Texto completo da fonteKennedy, Craig H., e Kim A. Meyer. "The Use of Psychotropic Medication for People with Severe Disabilities and Challenging Behavior: Current Status and Future Directions". Journal of the Association for Persons with Severe Handicaps 23, n.º 2 (junho de 1998): 83–97. http://dx.doi.org/10.2511/rpsd.23.2.83.
Texto completo da fonteTataru, Alexandra, George Tătaru, Floris Petru Iliuță, Alexandra Maștaleru, Irina Mihaela Abdulan, Carmen Marinela Cumpăt, Ingrid Georgiana Mihoc, Cozmin Mihai e Raluca Ioana Modoranu. "The interactions between psychotropic medication and drugs used in the treatment of cardiovascular diseases". Bulletin of Integrative Psychiatry 101, n.º 2 (15 de junho de 2024): 67–76. http://dx.doi.org/10.36219/bpi.2024.2.07.
Texto completo da fonteFord, Loretta T., e Jonathan D. Berg. "Analytical evidence to show letters impregnated with novel psychoactive substances are a means of getting drugs to inmates within the UK prison service". Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 55, n.º 6 (30 de março de 2018): 673–78. http://dx.doi.org/10.1177/0004563218767462.
Texto completo da fonteHalaris, Angelos. "Antidepressant Drug Therapy in the Elderly: Enhancing Safety and Compliance". International Journal of Psychiatry in Medicine 16, n.º 1 (março de 1987): 1–19. http://dx.doi.org/10.2190/uhl6-0x4w-frng-8pff.
Texto completo da fontePetrykiv, S., M. Arts e L. De Jonge. "Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs". European Psychiatry 65, S1 (junho de 2022): S454. http://dx.doi.org/10.1192/j.eurpsy.2022.1152.
Texto completo da fonteBaumann, P. "JS01-01 - Pharmacokinetics of psychotropic drugs - keys for treatments’ improvements". European Psychiatry 26, S2 (março de 2011): 1995. http://dx.doi.org/10.1016/s0924-9338(11)73698-7.
Texto completo da fonteLozzi, Flavia, Cosimo Di Raimondo, Caterina Lanna, Laura Diluvio, Sara Mazzilli, Virginia Garofalo, Emi Dika et al. "Latest Evidence Regarding the Effects of Photosensitive Drugs on the Skin: Pathogenetic Mechanisms and Clinical Manifestations". Pharmaceutics 12, n.º 11 (17 de novembro de 2020): 1104. http://dx.doi.org/10.3390/pharmaceutics12111104.
Texto completo da fonteAmpong, David Nana. "Landmarks of pharmacogenomics and some considerations for clinical practice". Therapeutic Advances in Psychopharmacology 9 (janeiro de 2019): 204512531989665. http://dx.doi.org/10.1177/2045125319896650.
Texto completo da fonteKocharyan, Garnik. "Hypoactive Sexual Desire and Other Sexual Dysfunctions Caused by Psychotropic Drugs and Anticonvulsants". Health of Man, n.º 1 (31 de março de 2023): 34–42. http://dx.doi.org/10.30841/2307-5090.1.2023.280049.
Texto completo da fonteOlczyk, Carla Joice Tomczak, e Eduardo Manoel Pereira. "Analysis of antimicrobial and psychotropic prescriptions in the central medication unit of the city of Guaramirim (Santa Catarina State - Brazil) / Análise de prescrições de antimicrobianos e psicotrópicos na unidade central de medicamentos da cidade de Guaramirim (Estado de Santa Catarina - Brasil)". Brazilian Journal of Development 8, n.º 5 (20 de maio de 2022): 39527–42. http://dx.doi.org/10.34117/bjdv8n5-443.
Texto completo da fontePrisco, V., T. Iannaccone, A. Capuano, M. Fabrazzo e F. Catapano. "Drug safety warnings in psychiatry: Adverse drug reactions’ signaling from 2002 to 2014". European Psychiatry 41, S1 (abril de 2017): S758. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1420.
Texto completo da fonteCreeley e Denton. "Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes". Brain Sciences 9, n.º 9 (14 de setembro de 2019): 235. http://dx.doi.org/10.3390/brainsci9090235.
Texto completo da fonte